Abstract
Lipids in biological membranes are asymmetrically distributed across the bilayer. The choline-containing lipids, phosphatidylcholine (PtdCho) and sphingomyelin (SM), are more abundant in the external leaflet. In contrast, the amino-containing glycerophospholipids, phosphatidylserine (PtdSer) and phosphatidylethanolamine (PtdEth), are located preferentially on the cytoplasmic leaflet. The maintenance of transbilayer lipid asymmetry is essential for normal membrane function, and disruption of this asymmetry is associated with cell activation or pathological condition. The physiological role of ceramide formation in response to cell stimulation remains controversial. Ceramide formation serves many different functions at various locations in the cell. Despite the limited capacity for spontaneous intracellular diffusion or membrane flip-flop of lipids in membranes, we have found that ceramide production, via sphingomyelinase action or addition of external ceramide, induces the transbilayer lipid motion of the lipids within the cellular membrane. This chapter outlines various commonly used assays for measuring lipid flip-flop induced by ceramide in cell and model membranes.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kornberg RD, McConnell HM. Lateral diffusion of phospholipids in a vesicle membrane. Proc Natl Acad Sci USA 1971;68:2564–8.
Connor J, Schroit AJ. Determination of lipid asymmetry in human red cells by resonance energy transfer. Biochemistry 1987;26:5099–105.
Zachowski A, Herrmann A, Paraf A, Devaux PF. Phospholipid outside-inside translocation in lymphocyte plasma membranes is a protein-mediated phenomenon. Biochim Biophys Acta 1987;897:197–200.
Van Helvoort A, Smith AJ, Sprong H, Fritzsche I, Schinkel AH, Borst P, van Meer G. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 1996;87:507–17.
Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denefle P, Assmann G. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 1999;22:352–5.
Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HO, Loubser O, Ouelette BF, Fichter K, Ashbourne-Excoffon KJ, Sensen CW, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJ, Genest J, Jr., Hayden MR. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999;22:336–45.
Sims PJ, Wiedmer T. Unraveling the mysteries of phospholipid scrambling. Thromb Haemost 2001;86:266–75.
Fadok VA, Bratton DL, Frasch SC, Warner ML, Henson PM. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ 1998;5:551–62.
Connor J, Pak CC, Schroit AJ. Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationship to cell density, cell age, and clearance by mononuclear cells. J Biol Chem 1994;269:2399–404.
Hannun YA, Luberto C. Ceramide in the eukaryotic stress response. Trends Cell Biol 2000;10:73–80.
Levade T, Jaffrezou JP. Signalling sphingomyelinases: Which, where, how and why? Biochim Biophys Acta 1999;438:1–17.
Perry DK. Ceramide and apoptosis. Biochem Soc Trans 2000;27:399–404.
Goñi FM, Alonso A. Sphingomyelinases: Enzymology and membrane activity. FEBS Lett 2002;531:38–46.
Spiegel S, Foster D, Kolesnick R. Signal transduction through lipid second messengers. Curr Opin Cell Biol 1996;8:159–67.
Kolesnick RN, Kronke M. Regulation of ceramide production and apoptosis. Ann Rev Physiol 1998;60:643–5.
Dobrowsky RT, Hannun YA. Ceramide stimulates a cytosolic protein phosphatase. J Biol Chem 1992;267:5048–51.
Zhang Y, Yao B, Delikat S, Bayoumy S, Lin XH, Basu S, McGinley M, Chan-Hui PY, Lichenstein H, Kolesnick R. Kinase suppressor of ras is ceramide-activated protein kinase. Cell 1997;89:63–72.
Lee JY, Hannun YA, Obeid LM. Ceramide inactivates cellular protein kinase C alpha. J Biol Chem 1996;271:13169–74.
Veiga MP, Arrondo JL, Goni FM, Alonso A. Ceramides in phospholipid membranes: Effects on bilayer stability and transition to nonlamellar phases. Biophys J 1999;76:342–50.
Montes LR, Ruiz-Argüello MB, Goñi FM, Alonso A. Membrane restructuring via ceramide results in enhanced solute efflux. J Biol Chem 2002;277:11788–94.
Siskind LJ, Colombini M. The lipids C2- and C16-ceramide form large stable channels. Implications for apoptosis. J Biol Chem 2000;275:38640–4.
Basañez G, Ruiz-Argüello MB, Alonso A, Goñi FM, Karlsson G, Edwards K. Morphological changes induced by phospholipase C and by sphingomyelinase on large unilamellar vesicles: A cryo-transmission electron microscopy study of liposome fusion. Biophys J 1997;72:2630–7.
Ruiz-Argüello MB, Basañez G, Goñi FM, Alonso A. Different effects of enzyme-generated ceramides and diacylglycerols in phospholipid membrane fusion and leakage. J Biol Chem 1996;271:26616–21.
Holopainen JM, Angelova MI, Kinnunen PKJ. Vectorial budding of vesicles by asymmetrical enzymatic formation of ceramides in giant liposomes. Biophys J 2000;78:830–8.
Bollinger CR, Teichgraber V, Gulbins E. Ceramide-enriched membrane domains. Biochim Biophys Acta 2005;1746:284–94.
Gulbins E, Li PL. Physiological and pathophysiological aspect of ceramide. Am J Physiol Regul Integr Comp Physiol 2006;290:R11–R26.
Lopez-Montero I, Rodríguez N, Cribier S, Pohl A, Velez M, Devaux PF. Rapid transbilayer movement of ceramides in phospholipid vesicles and in human erythrocytes. J Biol Chem 2005;280:25811–9.
Contreras FX, Villar AV, Alonso A, Kolesnick RN, Goñi FM. Sphingomyelinase activity causes transbilayer lipid translocation in model and cell membranes. J Biol Chem 2003;278:37169–74.
Contreras FX, Basanez G, Alonso A, Herrmann A, Goñi FM. Asymmetric addition of ceramides but not dihydroceramides promotes transbilayer (flip-flop) lipid motion in membranes. Biophys J 2005;88:348–59.
Müller P, Schiller S, Wieprecht T, Dathe M, Herrmann A. Continuous measurement of rapid transbilayer movement of a pyrene-labeled phospholipid analogue. Chem Phys Lipids 2000;106:89–99.
Mayer LD, Hope MH, Cullis PR. Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim Biophys Acta 1986;858:161–8.
Bottcher GJF, Van Gent CM, Pries C. A rapid and sensitive submicro phosphorus determination. Anal Chim Acta 1961;24:203–4.
Wybenga LE, Epand RF, Nir S, Chu JWK, Sharom FJ, Flanagan TD, Epand RM. Glycophorin as a receptor for Sendai virus. Biochemistry 1996;35:9513–9.
Steck TL, Kant JA. Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. Methods Enzymol 1974;31:172–80.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Contreras, FX., Villar, AV., Alonso, A., Goñi, F.M. (2009). Ceramide-Induced Transbilayer (Flip-Flop) Lipid Movement in Membranes. In: Larijani, B., Woscholski, R., Rosser, C. (eds) Lipid Signaling Protocols. Methods in Molecular Biology, vol 462. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-115-8_10
Download citation
DOI: https://doi.org/10.1007/978-1-60327-115-8_10
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-58829-727-3
Online ISBN: 978-1-60327-115-8
eBook Packages: Springer Protocols